Spero Therapeutics Inc (SPRO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.21
• Market Cap: $125.07M
• EPS: $-0.79
• 52-Week High: $3.22
• 52-Week Low: $0.51

Market Sentiment

Spero Therapeutics Inc currently has a Bearish sentiment score of -0.27.

About Spero Therapeutics Inc

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, dedicated to addressing the pressing challenge of multidrug resistant (MDR) bacterial infections and rare diseases. The company is focused on innovating and advancing novel therapeutics through a robust pipeline, aiming to deliver impactful solutions that improve patient outcomes. With a commitment to combating resistance in bacterial pathogens, Spero is positioned at the forefront of add...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Spero Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SPRO pay dividends?

Spero Therapeutics Inc (SPRO) does not currently pay a regular dividend.

What is SPRO's market cap?

Spero Therapeutics Inc (SPRO) has a market capitalization of $125.07M with a current stock price of $2.21.